Abstract:Purpose: This study aimed to investigate the relationship between gut microbiota (GM) and serum metabolism using antineoplastic Fufangchangtai (FFCT) as the model prescription in the treatment of colorectal cancer (CRC). Methods: Tumor-bearing mice and normal mice were administered different doses of FFCT. The tumor volume of tumor-bearing mice was observed. The levels of CD4 + and CD8 + T cells in the blood, spleen, and tumor of mice were determined using a flow cytometer. The bacterial microbiota in stool samples from mice and the serum metabolomics of FFCT-treated mice and fecal microbiota transplantation mice were detected using 16s RNA sequencing and liquid chromatography–mass spectrometry (LC/MS), respectively. Results: The tumor volume of mice showed no significant decrease after FFCT intervention. The levels of CD4 + and CD8 + T lymphocytes showed a significant increase under the intervention of FFCT. GM of colorectal tumor-bearing mice and healthy mice were determined, and the diversity and abundance of Firmicutes , Deferribacteres , Bacteroidetes , and Proteobacteria were significantly different between the two groups. Furthermore, we found that the levels of matrine, isogingerenone B, and armillaripin were significantly decreased in tumor-bearing mice after FFCT intervention, indicating that the tumor-induced dysbiosis of gut bacteria may affect the absorption and metabolism of FFCT. Under the intervention of FFCT, serum metabolism of mice transplanted with feces from CRC patients showed less metabolites related to FFCT than that from healthy people, indicating that GM could be a single factor affecting the metabolism of FFCT. Furthermore, we found that different doses of FFCT-treated mice had higher abundance of Roseburia , Turicibacter , and Flexispira than that in the non-intervention control group. Firmicutes and Bacteroidetes in FFCT-treated groups showed a similar trend compared to the healthy group, indicating that FFCT might correct the intestinal microenvironment by modulating gut microbiota in colorectal tumor-bearing mice. Conclusion: The dysbiosis of GM in tumor-bearing mice reduced the serum metabolites related to FFCT, and FFCT could correct the disordered GM of colorectal tumor-bearing mice to exert efficacy.

The antitumour effects of caloric restriction are mediated by the gut microbiome

Caloric Restriction, Friend or Foe: Effects on Metabolic Status in Association with the Intestinal Microbiome and Metabolome

Long-term intermittent caloric restriction remodels the gut microbiota in mice genetically prone to breast cancer

Caloric Restriction Alleviates Radiation Injuries in a Sex‐dependent Fashion

The Effect of Calorie Intake, Fasting, and Dietary Composition on Metabolic Health and Gut Microbiota in Mice

Predominant gut Lactobacillus murinus strain mediates anti-inflammaging effects in calorie-restricted mice

Caloric Restriction Remodels Energy Metabolic Pathways of Gut Microbiota and Promotes Host Autophagy

Calorie restriction and its impact on gut microbial composition and global metabolism

Effects of caloric restriction on the gut microbiome are linked with immune senescence

A More Robust Gut Microbiota in Calorie-Restricted Mice is Associated with Attenuated Intestinal Injury Caused by the Chemotherapy Drug Cyclophosphamide

Calorie restriction and diet composition modulate spontaneous intestinal tumorigenesis in Apc(Min) mice through different mechanisms

Effect of Intermittent versus Chronic Calorie Restriction on Tumor Incidence: A Systematic Review and Meta-Analysis of Animal Studies

Disordered Gut Microbiota in Colorectal Tumor-Bearing Mice Altered Serum Metabolome Related to Fufangchangtai

Caloric restriction counteracts chemotherapy-induced inflammation and increases response to therapy in a triple negative breast cancer model

Caloric restriction disrupts the microbiota and colonization resistance

Gut Microbiome Couples Gut and Brain During Calorie Restriction in Treating Obesity

Effect of Caloric Restriction on BMI, Gut Microbiota, and Blood Amino Acid Levels in Non-Obese Adults

Calorie restriction and breast cancer treatment: a mini-review

Time-restricted feeding affects the fecal microbiome metabolome and its diurnal oscillations in lung cancer mice

Gut microbiota-derived short-chain fatty acids regulate gastrointestinal tumor immunity: a novel therapeutic strategy?

Caloric restriction leading to attenuation of experimental Alzheimer's disease results from alterations in gut microbiome